BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2776834)

  • 1. The use of ryanodine and calcium channel blockers to characterize intra- and extracellular calcium pools mobilized by noradrenaline in the rat vas deferens.
    Vesperinas G; Feddersen M; Lewin J; Huidobro-Toro JP
    Eur J Pharmacol; 1989 Jun; 165(2-3):309-13. PubMed ID: 2776834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
    Burt RP; Chapple CR; Marshall I
    Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens.
    Hay DW; Wadsworth RM
    Br J Pharmacol; 1982 May; 76(1):103-13. PubMed ID: 7082900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different actions in the rat prostatic and epididymal vas deferens of cyclopiazonic acid or ryanodine on noradrenaline-induced contractions.
    Amobi NI; Smith IC
    Gen Pharmacol; 1999 Feb; 32(2):271-8. PubMed ID: 10188631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of calcium channel inhibitors on twitches and noradrenaline contractions of the rat bisected vas deferens.
    Hay DW; Wadsworth RM
    Eur J Pharmacol; 1983 Mar; 87(4):367-78. PubMed ID: 6303798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine and ryanodine on adrenergic neurogenic contractions of rat vas deferens: evidence for a pulse-to-pulse change in Ca2+ sources.
    Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Apr; 108(4):1062-70. PubMed ID: 8485618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine- and cyclopiazonic acid-sensitive components in human vas deferens contractions to noradrenaline.
    Amobi NI; Smith IC
    J Auton Pharmacol; 1998 Jun; 18(3):167-76. PubMed ID: 9754637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium antagonists on the response to noradrenaline in the whole and bisected rat vas deferens.
    Boselli C; Bianchi L; Barbieri A; Grana E
    J Auton Pharmacol; 1998 Oct; 18(5):297-306. PubMed ID: 9831230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ryanodine and nifedipine on contractions induced by norepinephrine, acetylcholine, and potassium in the isolated vas deferens of the guinea pig.
    Tsunobuchi H; Gomi Y
    J Pharmacobiodyn; 1990 Sep; 13(9):574-80. PubMed ID: 2084228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromechanical coupling in human vas deferens: effects of agents that modulate intracellular release of calcium.
    Amobi NI; Smith IC
    J Auton Pharmacol; 1998 Jun; 18(3):157-65. PubMed ID: 9754636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postjunctional alpha 1- and beta-adrenoceptor effects of noradrenaline on electrical slow waves and phasic contractions of cat colon circular muscle.
    Venkova K; Krier J
    Br J Pharmacol; 1995 Dec; 116(8):3265-73. PubMed ID: 8719806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BaCl2- and 4-aminopyridine-evoked phasic contractions in the rat vas deferens.
    Huang Y
    Br J Pharmacol; 1995 Jul; 115(5):845-51. PubMed ID: 8548186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative importance of extracellular and intracellular calcium in the responses of the human vas deferens to noradrenaline and potassium: a study using Ca(2+)-deprivation and Ca(2+)-antagonists.
    Amobi NI; Smith CH
    J Auton Pharmacol; 1993 Jun; 13(3):177-92. PubMed ID: 8514820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of calcium channel inhibitors and other procedures affecting calcium translocation on drug-induced rhythmic contractions in the rat vas deferens.
    Hay DW; Wadsworth RM
    Br J Pharmacol; 1983 Jun; 79(2):347-62. PubMed ID: 6652333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP-mediated inhibition of noradrenaline-induced contraction and Ca2+ influx in guinea-pig vas deferens.
    Kato K; Furuya K; Tsutsui I; Ozaki T; Yamagishi S
    Exp Physiol; 2000 Jul; 85(4):387-98. PubMed ID: 10918078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens.
    Bültmann R; Kurz AK; Starke K
    Br J Pharmacol; 1994 Jan; 111(1):151-8. PubMed ID: 7912153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heptanol on noradrenaline-induced contractions in rat vas deferens.
    Palani D; Manchanda R
    J Smooth Muscle Res; 2006 Feb; 42(1):49-61. PubMed ID: 16702763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage and time dependency of calcium mediated phasic and tonic responses in rat vas deferens smooth muscle--the effect of some calcium agonist and antagonist agents.
    Langton PD; Huddart H
    Gen Pharmacol; 1988; 19(6):775-87. PubMed ID: 2465934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ryanodine on the smooth muscle of the rat vas deferens.
    Khoyi MA; Westfall DP
    Proc West Pharmacol Soc; 1988; 31():91-3. PubMed ID: 3211926
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effects of T-type and L-type Ca(2+)-antagonists against noradrenaline-induced contractions of human vas deferens.
    Amobi N; Guillebaud J; Smith CH
    BJU Int; 2010 Aug; 106(4):578-85. PubMed ID: 20002677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.